These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 712896)

  • 21. [Combined urodynamic-electromyography study in patients with multiple sclerosis and bladder disorders].
    Venetz U; Casanova G; Hess CW; Ludin HP
    Nervenarzt; 1989 Mar; 60(3):163-7. PubMed ID: 2716933
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
    Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
    Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of neuropathic bladder in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A
    Clin Ter; 2004 May; 155(5):183-6. PubMed ID: 15344566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and therapy for neurogenic bladder dysfunctions in multiple sclerosis patients.
    Del Popolo G; Panariello G; Del Corso F; De Scisciolo G; Lombardi G
    Neurol Sci; 2008 Dec; 29 Suppl 4():S352-5. PubMed ID: 19089675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current management of neurogenic bladder in patients with MS.
    Woodward S
    Br J Nurs; 2004 Apr 8-21; 13(7):362-70. PubMed ID: 15150474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urodynamic abnormalities in two brothers with adrenomyeloneuropathy.
    Walther MM; Cutler GB
    World J Urol; 1997; 15(4):262-5. PubMed ID: 9280056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
    Khavari R; Karmonik C; Shy M; Fletcher S; Boone T
    J Urol; 2017 Feb; 197(2):438-444. PubMed ID: 27664581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maximal external electrical stimulation for treatment of neurogenic or non-neurogenic urgency and/or urge incontinence.
    Primus G; Kramer G
    Neurourol Urodyn; 1996; 15(3):187-94. PubMed ID: 8732985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
    Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
    Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Symptomatic therapy of bladder hyporeflexia in patients with multiple sclerosis].
    Stankovich EIu; Ovcharov VV; Gol'tsova NV; Klimov IuA; Afonin DV; Zolotova SN; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):135-7. PubMed ID: 19891358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
    Fletcher SG; Dillon BE; Gilchrist AS; Haverkorn RM; Yan J; Frohman EM; Lemack GE
    Mult Scler; 2013 Aug; 19(9):1169-74. PubMed ID: 23339136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical findings of neurogenic bladder in patients with Parkinson's disease, multiple sclerosis and spinocerebellar degeneration].
    Shimizu K; Yasukawa M; Yamamoto M; Hirao Y; Momose H; Kashiwai H; Kawata Y; Yamada K
    Hinyokika Kiyo; 1997 Nov; 43(11):765-9. PubMed ID: 9436018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study.
    McClurg D; Ashe RG; Marshall K; Lowe-Strong AS
    Neurourol Urodyn; 2006; 25(4):337-48. PubMed ID: 16637070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluid Intake and Urinary Symptoms in Patients with Multiple Sclerosis.
    Tam J; Gross MD; Cheung A; Melville PM; Kim JM; Weissbart SJ
    J Urol; 2020 Dec; 204(6):1284-1289. PubMed ID: 32924823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Symptomatic therapies for multiple sclerosis].
    Honda H
    Nihon Rinsho; 2003 Aug; 61(8):1355-60. PubMed ID: 12962023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuro-muscular dysfunction of the lower urinary tract in multiple sclerosis.
    Van Poppel H; Vereecken RL; Leruitte A
    Paraplegia; 1983 Dec; 21(6):374-9. PubMed ID: 6664687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis.
    Lemack GE; Frohman EM; Zimmern PE; Hawker K; Ramnarayan P
    Urology; 2006 May; 67(5):960-4. PubMed ID: 16635509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genitourinary changes in multiple sclerosis: the need for a urodynamic study].
    Martín C; Salinas J; Fernández-Durán A; Fernández-Gómez J; Jiménez N; Gangoiti L
    Rev Neurol; 2000 Apr 1-15; 30(7):643-8. PubMed ID: 10859743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
    Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
    Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Event driven electrical stimulation of the dorsal penile/clitoral nerve for management of neurogenic detrusor overactivity in multiple sclerosis.
    Fjorback MV; Rijkhoff N; Petersen T; Nohr M; Sinkjaer T
    Neurourol Urodyn; 2006; 25(4):349-55. PubMed ID: 16673380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.